Mithra Pharmaceuticals SA

05/06/2022 | Press release | Distributed by Public on 05/06/2022 09:51

Publication of a Transparency Notification Received from Glenernie Capital

Liege, Belgium, 06 May 2022 - 17:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health today announces, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received a notification of transparency from Glenernie Capital Ltd, with registered offices at Smithson Plaza, 13th Floor, 25 St. James's Street, London SW1A 1HA, on 3, May 2022. Glenernie Capital has notified Mithra that it has exceeded the statutory 3% threshold on 28, April 2022.